Archive for News Report

Boehringer spells out a $448M future for Rectify’s ABC kidney disease program

December 23, 2025

Reinventing Drug Discovery with AI: Marc Tessier-Lavigne on The Long Run

November 14, 2025

Inflammation biotech Evommune heads to NYSE with $150M IPO

November 10, 2025

Evommune nabs $150M in IPO amid federal shutdown

November 10, 2025

EQT-Backed Biotech Firm Evommune Raises $150 Million in IPO

November 10, 2025

Italian biotech AAVantgarde adds $141M series B to fund retinal disease gene therapy trials

November 3, 2025